CENNA BIOSCIENCES

cenna-biosciences-logo

Cenna Biosciences develops disease modifying drugs for Alzheimer's disease using a proprietary novel mechanism.

#SimilarOrganizations #People #Website #More

CENNA BIOSCIENCES

Industry:
Biopharma Biotechnology Life Science Medical

Founded:
2006-01-01

Address:
La Jolla, California, United States

Country:
United States

Website Url:
http://www.cennabiosciences.com

Total Employee:
1+

Status:
Active

Contact:
858-456-0820

Email Addresses:
[email protected]

Technology used in webpage:
Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS


Similar Organizations

anven-biosciences-logo

AnVen BioSciences

AnVen BioSciences is a developer and provider of molecular diagnostic and prognostic tests for a variety of diseases.

m6p-therapeutics-logo

M6P Therapeutics

M6P Therapeutics develops biotechnology advances for lysosomal storage diseases.

penn-medicine-co-investment-program-logo

Penn Medicine Co-Investment Program

Penn Medicine Co-Investment Program makes investments in faculty-driven cell therapy, gene therapy, and connected health companies

Current Employees Featured

not_available_image

Nazneen Dewji
Nazneen Dewji Founder @ Cenna Biosciences
Founder

not_available_image

Jonathan Singer
Jonathan Singer Founder @ Cenna Biosciences
Founder

Founder


not_available_image

Jonathan Singer

not_available_image

Nazneen Dewji

Official Site Inspections

http://www.cennabiosciences.com Semrush global rank: 8.64 M Semrush visits lastest month: 274

  • Host name: 41.137.120.34.bc.googleusercontent.com
  • IP address: 34.120.137.41
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Cenna Biosciences"

Developing Disease-Modifying Drugs for Alzheimer's Disease

Cenna is revolutionizing Alzheimer's treatment with proprietary small peptides and molecules that inhibit beta amyloid production. Learn more about our disease-modifying drugs for Alzheimer's โ€ฆSee details»

Cenna Biosciences - Crunchbase Company Profile & Funding

Cenna Biosciences develops disease modifying drugs for Alzheimer's disease using a proprietary novel mechanism.See details»

Cenna Biosciences Inc. Company Profile | La Jolla, CA | Competitors ...

Find company research, competitor information, contact details & financial data for Cenna Biosciences Inc. of La Jolla, CA. Get the latest business insights from Dun & Bradstreet.See details»

Cenna Biosciences Company Profile | Management and Employees โ€ฆ

Find contact information for Cenna Biosciences. Learn about their Research & Development, Business Services market share, competitors, and Cenna Biosciences's email format.See details»

Cenna Biosciences - VentureRadar

"Cenna Biosciences, Inc. is a privately-held biopharmaceutical company in La Jolla CA, focused on the discovery and development of novel drugs for the prevention and treatment of โ€ฆSee details»

Cenna Biosciences - LinkedIn

Cenna Biosciences Receives NIH NIA Phase II SBIR Award for the Early Clinical Development of Nubytide TM, a First-in-Class, Disease-Modifying Peptide Drug for the Prevention and โ€ฆSee details»

Cenna Biosciences - Org Chart, Teams, Culture & Jobs | The Org

View Cenna Biosciences' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Cenna Biosciences Company Profile 2024: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for Cenna Biosciences. Use the PitchBook Platform to explore the full profile.See details»

Cenna Biosciences - Products, Competitors, Financials, Employees ...

About Cenna Biosciences Cenna Biosciences focuses on developing disease-modifying drugs for Alzheimer's Disease within the biopharmaceutical industry. The company's main offering is a โ€ฆSee details»

Cenna Biosciences - Overview, News & Similar companies

Jul 29, 2021 View Cenna Biosciences (www.cennabiosciences.com) location in California, United States , revenue, industry and description. Find related and similar companies as well โ€ฆSee details»

Cenna Biosciences Company Profile - Office Locations ... - Craft

Cenna Biosciences has 5 employees at their 1 location. See insights on Cenna Biosciences including office locations, competitors, revenue, financials, executives, subsidiaries and more โ€ฆSee details»

Cenna Biosciences, Inc.: Drug pipelines, Patents, Clinical trials

Explore Cenna Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, and 2 literature, Disease Domain:Nervous System Diseases ...See details»

Cenna Biosciences, Inc.:Company Profile & Technical โ€ฆ

Oct 6, 2023 Cenna Biosciences, Inc. is a company that provides Biology, Drug, Alzheimer's disease and more. Cenna Biosciences, Inc. is headquartered in United States California. โ€ฆSee details»

Cenna Biosciences - VentureRadar

Cenna Biosciences, Inc. is a privately-held biopharmaceutical company in La Jolla CA, focused on the discovery and development of novel drugs for the prevention and treatment of Alzheimerโ€™s โ€ฆSee details»

Cenna Biosciences Inc. - Golden

Cenna Biosciences Inc. is an alzheimer's Drugs Targeting Amyloid Beta.Alzheimer's Drugs Targeting Amyloid BetaSee details»

Cenna Biosciences Receives NIH NIA Phase II SBIR Award for the โ€ฆ

Sep 23, 2024 LA JOLLA, CA / ACCESSWIRE / September 23, 2024 / Cenna Biosciences Inc., a privately-held biopharmaceutical company based in La Jolla, California, and focused on โ€ฆSee details»

Cenna Announces Appointment of David H. Crean to Board of โ€ฆ

Dec 20, 2023 Cenna has a transformational, novel and different patented technology that arrests the underlying cause of the disease and addresses previous failures by others. IND filing of โ€ฆSee details»

Cenna Biosciences, Inc. (Cenna Biosciences, Inc.) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ โ€ฆ

Contact Information Nazneen Dewji President and CEO, Cenna Biosciences [email protected] (858) 456-0821 SOURCE: Cenna Biosciences Inc. View the โ€ฆSee details»

Cenna Biosciences Receives NIH NIA Phase II SBIR Award for the โ€ฆ

Sep 23, 2024 Cenna Biosciences Receives NIH NIA Phase II SBIR Award for the Early Clinical Development of Nubytide TM, a First-in-Class, Disease-Modifying Peptide Drug for the โ€ฆSee details»

Cenna Biosciences Receives NIH NIA Phase II SBIR Award for

Sep 23, 2024 LA JOLLA, CA / ACCESSWIRE / September 23, 2024 / Cenna Biosciences Inc., a privately-held biopharmaceutical company based in La Jolla, California, and focused on โ€ฆSee details»

linkstock.net © 2022. All rights reserved